Jeffrey A Kaye Selected Research

Jeffrey A Kaye Research Topics

Disease

29	Alzheimer Disease (Alzheimer's Disease) 07/2022 - 08/2002
17	Cognitive Dysfunction 01/2022 - 04/2002
13	Dementia (Dementias) 01/2020 - 02/2004
4	Amyloid Plaque 05/2013 - 09/2012
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2012 - 06/2004
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2011 - 03/2010
2	Frontotemporal Dementia (Semantic Dementia) 04/2011 - 03/2010
2	Disease Progression 08/2008 - 03/2005
1	COVID-19 01/2022
1	Diarrhea 10/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2019
1	Tauopathies 10/2019
1	Postoperative Cognitive Complications 01/2019
1	Lewy Body Disease (Lewy Body Dementia) 01/2018
1	Amyloid angiopathy 05/2013
1	Infarction (Infarctions) 05/2013
1	Synucleinopathies 02/2013
1	Neuroblastoma 09/2012
1	Hypertension (High Blood Pressure) 07/2009
1	Prodromal Symptoms 08/2008
1	Multiple Sclerosis 05/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2005
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 06/2004

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2002
9	Apolipoproteins E (ApoE)IBA 01/2021 - 04/2002
6	Amyloid (Amyloid Fibrils)IBA 10/2019 - 10/2011
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2005
6	ApolipoproteinsIBA 01/2018 - 04/2002
4	LipidsIBA 01/2021 - 10/2015
3	Amyloid beta-PeptidesIBA 12/2011 - 07/2006
2	Peptides (Polypeptides)IBA 10/2019 - 10/2012
2	Apolipoprotein E4IBA 01/2019 - 07/2009
2	DiglyceridesIBA 10/2015 - 01/2015
2	DNA-Binding Proteins (DNA Binding Protein)IBA 04/2011 - 03/2010
2	ProgranulinsIBA 04/2011 - 03/2010
2	AntioxidantsIBA 01/2009 - 03/2005
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2009 - 02/2004
2	F2-Isoprostanes (F2 Isoprostanes)IBA 02/2004 - 08/2002
1	Contrast MediaIBA 01/2022
1	2- acetamido- 1,3,6- tri- O- acetyl- 2,4- dideoxyhexopyranoseIBA 01/2022
1	Phosphotransferases (Kinase)IBA 10/2019
1	saracatinibIBA 10/2019
1	Prion ProteinsIBA 10/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	phosphatidylethanolamineIBA 10/2015
1	phosphatidal ethanolaminesIBA 10/2015
1	PlasmalogensIBA 10/2015
1	Phosphatidylethanolamines (Cephalins)IBA 10/2015
1	MonoglyceridesIBA 10/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2015
1	Alanine (L-Alanine)FDA Link 02/2015
1	Threonine (L-Threonine)FDA Link 02/2015
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 09/2012
1	3' Untranslated Regions (3' UTR)IBA 09/2012
1	ADAM10 ProteinIBA 09/2012
1	Indicators and Reagents (Reagents)IBA 08/2012
1	HDL CholesterolIBA 01/2012
1	Triglycerides (Triacylglycerol)IBA 01/2012
1	ProteomeIBA 10/2011
1	Chromogranin AIBA 01/2011
1	aminoacyl-histidine dipeptidaseIBA 01/2011
1	Prealbumin (Transthyretin)IBA 01/2011
1	Cystatin CIBA 01/2011
1	MicronutrientsIBA 10/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2010
1	Excitatory Amino Acid Transporter 2IBA 07/2010
1	Detergents (Detergent)IBA 07/2010
1	P-2 (P 2)IBA 03/2010
1	AlbuminsIBA 01/2009
1	RNA (Ribonucleic Acid)IBA 04/2008
1	Phospholipids (Phosphatides)FDA LinkGeneric 05/2005
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2004
1	Metalloproteases (Metalloproteinases)IBA 06/2004
1	Matrix Metalloproteinases (MMPs)IBA 06/2004
1	alpha-Tocopherol FDA Link 02/2004

Therapy/Procedure

7	Therapeutics 01/2018 - 08/2002
1	Phototherapy (Light Therapy) 07/2022
1	Activities of Daily Living (ADL) 10/2019
1	Anesthesia 01/2016
1	Ambulatory Care (Outpatient Care) 01/2015
1	Home Nursing (Nursing, Home) 01/2010